NCT00328380View on ClinicalTrials.gov

Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

September 30, 2008

Conditions
Diarrhea
Interventions
DRUG

Rifaximin

Trial Locations (3)

33143

Sunshine Medical Center, South Miami

77004

Southwest Doctors, PA, Houston

77571

La Porte Family Clinic, La Porte

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00328380 - Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. | Biotech Hunter | Biotech Hunter